Status:

COMPLETED

Midazolam Versus Dexamethasone as an Adjuvant to Local Anesthetics in the Ultrasound Guided Hydrodissection of Median Nerve for Treatment of Carpal Tunnel Syndrome Patients

Lead Sponsor:

Minia University

Conditions:

Pain Syndrome

Eligibility:

All Genders

30-70 years

Phase:

NA

Brief Summary

midazolam and dexamethasone both can counteract chronic pain. either via GABA mimetic action or via anti prostaglandins

Detailed Description

Entrapement syndrome - namely median nerve compression in carpal tunnel syndrome - causes chronic pain that can be refractory to medical treatment . Ultrasound guided hydrodissection is an option for ...

Eligibility Criteria

Inclusion

  • numbness or pain in the nerve distribution, nerve conduction studies (NCS) corresponding with AANEM guidelines
  • Nerve cross sectional area \>12mm2

Exclusion

  • Refusal to participate
  • History of operation in median nerve.were patient refusal to participate, pain recurrence after previous injection and severe symptoms requiring surgical release, diabetic patients

Key Trial Info

Start Date :

September 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2021

Estimated Enrollment :

134 Patients enrolled

Trial Details

Trial ID

NCT04527770

Start Date

September 1 2020

End Date

April 30 2021

Last Update

February 18 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mina Maher Raouf

ALMinya, Egypt, Egypt, 6115

Midazolam Versus Dexamethasone as an Adjuvant to Local Anesthetics in the Ultrasound Guided Hydrodissection of Median Nerve for Treatment of Carpal Tunnel Syndrome Patients | DecenTrialz